Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In
Big effect

L-Carnitine added 53 meters to COPD patients' six-minute walk distance — a gain comparable to pulmonary rehab, though the analysis didn't specify the dose or confirm blinding.

This is among the first meta-analyses to isolate L-Carnitine's effect on exercise capacity in COPD, and the 53-meter improvement is clinically meaningful — but because the dose is unreported and the underlying trials weren't blinded, the effect may shrink in better-controlled studies.

In a network meta-analysis of nutritional supplements for COPD, L-Carnitine was linked to a large average gain of 53 meters on the six-minute walk test, a standard measure of functional exercise endurance. However, the analysis didn't disclose the dose used across trials, and blinding wasn't applicable — meaning patients and clinicians knew which treatment was given, which can inflate perceived benefits. The same analysis also found that L-Carnitine improved lung function (FEV1%) and reduced breathlessness, but because the evidence base for this specific pairing is still thin, these results should be seen as promising but preliminary.

Where this fits in the evidence

This is among the first studies we've indexed on L-Carnitine for Improved 6-minute Walking Distance — treat it as an early signal until more research accumulates.

The study

Comparative Efficacy of Nutritional Supplements in Modulating Lung Function and Exercise Capacity in COPD Patients: A Network Meta-Analysis.

  • Systematic Review
  • 2025-05-17
  • International journal of chronic obstructive pulmonary disease
More on L-CarnitineMore on Improved 6-minute Walking Distance

This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.

Back to top